Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.98%||86.26||1.0%||$795.01m|
|VRTX||Vertex Pharmaceuticals, Inc.||-1.01%||312.98||1.9%||$482.01m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.12%||736.23||2.6%||$473.28m|
|SNSS||Sunesis Pharmaceuticals, Inc.||5.70%||2.78||0.7%||$194.33m|
|BMRN||BioMarin Pharmaceutical, Inc.||-0.89%||96.92||4.2%||$161.47m|
|MRTX||Mirati Therapeutics, Inc.||2.89%||98.62||1.6%||$132.21m|
|AXSM||Axsome Therapeutics, Inc.||1.07%||56.82||1.6%||$80.71m|
|HALO||Halozyme Therapeutics, Inc.||0.59%||54.67||18.4%||$64.50m|
Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in South San Francisco, CA.